utd_medknow
International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
 
 
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   
 


 
 Table of Contents  
LETTER TO EDITOR
Year : 2014  |  Volume : 6  |  Issue : 4  |  Page : 189  

Low-level laser therapy for androgenic alopecia


1 Medical Center, Shantou, China
2 Hainan Medical University, Haikou, China

Date of Web Publication14-Oct-2014

Correspondence Address:
Sim Sai Tin
Medical Center, Shantou
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-7753.142892

Rights and Permissions

How to cite this article:
Tin SS, Wiwanitkit V. Low-level laser therapy for androgenic alopecia. Int J Trichol 2014;6:189

How to cite this URL:
Tin SS, Wiwanitkit V. Low-level laser therapy for androgenic alopecia. Int J Trichol [serial online] 2014 [cited 2022 Jun 26];6:189. Available from: https://www.ijtrichology.com/text.asp?2014/6/4/189/142892

Sir,

We would like to discuss on the report on "low-level laser therapy for androgenic alopecia. [1]" Munck et al. have reported that "low-level laser therapy (LLLT) represents a potentially effective treatment for both male and female androgenetic alopecia, either as monotherapy or concomitant therapy. [1]" In fact, it is no doubt that LLLT is useful alopecia treatment. Nevertheless, there are issued to further study. Avci et al. noted that "the optimum wavelength, coherence and dosimetric parameters remain to be determined. [2]" In addition, as noted by Gupta and Daigle, [3] it is still requires for further good trial to conclude for the exact non bias result of LLLT. In available studies, including to the present report by Munck et al., [1] "power, confounding and analysis issues" are the common weak points.

According to the above commentary, the primary authors' responds in each topic will be further detailed. Regarding dosimetry, it is impossible to utilize pharmacokinetic information with topical agents to arrive at the exact clinical dosage of an "active." Therefore, it has become generally accepted, based on references in the scientific literature that Lower Level Laser Treatment with wavelengths between 630 and 670 nm, is "thought to induce proliferative activity in hair follicles resulting in terminalitzation of vellus hair follicles". [4] That is why 655 nm which is in between the above mentioned recognized wavelengths, has become the "gold standard" used in clinical studies to test for efficacy, based primarily on the objective measurement of hair density, and secondarily on global outcomes as judged by experts in the field. Regarding efficacy, this quote was contained in the already mentioned sentence, "in addition as noticed by Gupta and Daigle, [3] it is still requires for further good trial to conclude for the exact non-bias result of LLLT" Unfortunately the article by Gupta and Daigle [3] was written and submitted before publication occurred describing the comprehensive and definitive clinical study by Jimenez et al. [5] Therefore, it is understandable why they reached their conclusion. [3] The mentioned article of Jimenez et al. [5] is the most comprehensive one published to date in a peer-review journal and validates the use of 655 nm to achieve significant efficacy. This is the conclusion that Jimenez et al. reached, "we observed a statistically significant difference in the increase in terminal hair density between lasercomb and sham treated subjectsΌ our results suggest that low-level laser treatment may be an effective option to treat pattern hair loss in both men and women. [5]" The present study by Munck et al. [1] at least involved global evaluation which is also a key measurement of the visible changes in hair density and the results closely paralleled the results found in the 4 objective studies.

 
   References Top

1.Munck A, Gavazzoni MF, Trüeb RM. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. Int J Trichology 2014;6:45-9.  Back to cited text no. 1
    
2.Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med 2014;46:144-51.  Back to cited text no. 2
    
3.Gupta AK, Daigle D. The use of low-level light therapy in the treatment of androgenetic alopecia and female pattern hair loss. J Dermatolog Treat 2014;25:162-3.  Back to cited text no. 3
    
4.Bernstein EF. Hair growth induced by diode laser treatment. Dermatol Surg 2005;31:584-6.  Back to cited text no. 4
    
5.Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol 2014;15:115-27.  Back to cited text no. 5
    



This article has been cited by
1 Clinical Assessment of Anti-inflammatory Activity of 940 Nanometer Low Level laser Therapy on Carrageenan Induced Arthritis in Temporomandibular Joint in Wistar Albino Rats
Ali Imad Al-Khassaki, Jamal Noori Ahmed
Journal of Pure and Applied Microbiology. 2019; 13(1): 619
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed2888    
    Printed84    
    Emailed0    
    PDF Downloaded48    
    Comments [Add]    
    Cited by others 1    

Recommend this journal